X4 Pharmaceuticals Inc

Company Snapshot
61 North Beacon Street
Boston, MA 02134
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 70
https://www.x4pharma.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
($59,874,000)
($75,349,000)
($88,078,000)
Net Income
($62,131,000)
($88,696,000)
($93,867,000)
2020
Gross Profit
Operating Income
($59,874,000)
Net Income
($62,131,000)
2021
Gross Profit
Operating Income
($75,349,000)
Net Income
($88,696,000)
2022
Gross Profit
Operating Income
($88,078,000)
Net Income
($93,867,000)
The above data on X4 Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Paula Ragan
Director, President and Chief Executive Officer
$950,811
$2,908,953
$12,769
$3,872,533
Paula Ragan
$3,872,533
Director, President and Chief Executive Officer
Adam Mostafa
Corporate Secretary, Chief Financial Officer, Principal Accounting Officer and Treasurer
$698,613
$1,181,700
$569
$1,880,882
Adam Mostafa
$1,880,882
Corporate Secretary, Chief Financial Officer, Principal Accounting Officer and Treasurer
Mary DiBiase
Chief Operating Officer
$648,819
$1,181,700
$12,769
$1,843,288
Mary DiBiase
$1,843,288
Chief Operating Officer
David McGirr
Independent Director
$54,000
$7,734
$0
$61,734
David McGirr
$61,734
Independent Director
William Aliski
Independent Director
$42,788
$7,734
$0
$50,522
William Aliski
$50,522
Independent Director
X4 Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us